Alli use and safety. Read the new warnings.
The Alli Drug Facts are part of the product, not optional fine print. They explain who the OTC weight-loss aid is intended for, how it fits with diet and exercise, when a doctor or pharmacist should be consulted and which symptoms require stopping use.
FDA approved new language in 2026 about rare kidney injury and kidney stones. This guide highlights key label topics for readers comparing online offers; it is not individualized medication advice or a substitute for reading the full package label.
BUYER'S EDITION
FIRST
THE DRUG FACTS & SAFETY EDITION
01 / WHO THE LABEL ADDRESSES
Alli is not a general-purpose supplement.
The approved U.S. label describes Alli (orlistat 60 mg) as an OTC aid for weight loss in overweight adults age 18 and older when used with a reduced-calorie, low-fat diet. The instructions also make clear that diet and exercise are the starting points for weight management. The medicine works by blocking absorption of some dietary fat, not by eliminating the need for changes in daily habits.
The label says not to use it if you are not overweight, if you have had an organ transplant, if you are taking cyclosporine or if you have a diagnosed problem absorbing food. It also states that people who are pregnant or breastfeeding should not use it. Eligibility cannot be established by a commercial checkout form. Review the actual Drug Facts or consult a professional when circumstances are unclear.
02 / DIRECTIONS AND VITAMINS
The routine comes with dietary considerations.
For the labeled adult population, the 2026 Drug Facts specify one sealed capsule with each meal containing fat and no more than three capsules per day, alongside a reduced-calorie, low-fat eating and exercise program. Do not infer from a 120-capsule box that a particular daily schedule is required. Product instructions, missing meals and other factors can affect actual use, and a clinician or pharmacist should answer individual dosing questions.
Because orlistat can reduce absorption of some vitamins, the Alli label also directs taking a multivitamin once a day at bedtime. Our pack guide
03 / EXPECTED AND UNEXPECTED EFFECTS
Bowel changes are possible; some symptoms need evaluation.
The Drug Facts describe gas with oily spotting, loose stools and more frequent or hard-to-control bowel movements as possible effects because unabsorbed fat leaves the body. The label links a reduced-fat diet to a lower chance of these bowel changes. A retailer promising entirely side-effect-free weight loss is not presenting an honest picture of the product.
The label also advises stopping and consulting a doctor for symptoms of possible liver problems, including itching, yellowing skin or eyes, dark urine or loss of appetite, and for severe or continuing abdominal pain. People taking seizure medicines should seek medical guidance if seizures worsen or occur more often. These are reasons to prioritize accurate instructions and professional support rather than assuming an OTC label means no meaningful risks.
04 / THE 2026 FDA UPDATE
Rare kidney injury is now explicit in the OTC warning.
On June 10, 2026, FDA announced approved updates to Alli 60 mg Drug Facts after reviewing rare reports of kidney injury and kidney stones. People who have ever had kidney disease or kidney stones are directed to ask a healthcare professional before using the medication. The agency stated that the kidney-risk language is now aligned across approved OTC and higher-strength prescription orlistat products.
The updated warning tells users to stop and ask a doctor about serious back or groin pain, painful urination, blood in the urine, swelling of the legs or feet or decreased urination. These are not ordinary weight-loss milestones. The official FDA communication and 2026 Drug Facts are the appropriate sources for the full wording. Our seller verification guide
05 / MEDICATION REVIEW
Other medicines can make the decision more complex.
The OTC label asks people taking anticoagulants, amiodarone, diabetes medicines, thyroid disease medicines, seizure medicines, HIV antiretrovirals or other weight-loss products to consult a doctor or pharmacist before using Alli. The updated carton also lists previous gallbladder problems, pancreatitis and kidney disease or stones among conditions that merit medical advice. The purpose of these lists is not to self-adjust medication or decide which interaction matters most; that requires clinical input.
Prescription Xenical 120 mg has separate professional labeling, revised in September 2026, and should not be treated as a do-it-yourself substitute when a warning makes OTC use uncertain. Our brand comparison
The safety checkpoint
| Check | What to record |
|---|---|
| Do not use | Specific OTC prohibitions including organ transplant, cyclosporine, pregnancy/breastfeeding |
| Ask before use | Kidney disease or stones, other listed health conditions, interacting medicines |
| Stop and ask a doctor | Kidney warning symptoms, severe ongoing abdominal pain or liver warning signs |
| Daily context | Reduced-calorie, low-fat diet and the multivitamin directions |
Editorial checklist only. No merchant pricing, availability or clinical eligibility is verified by Alivexa.
Answers without the sales spin.
The answers below are general U.S. product information. The actual approved label and a healthcare professional are the better sources for personal questions.
What is new about Alli safety in 2026?
FDA strengthened the OTC Drug Facts warning about rare kidney injury and kidney stones and listed symptoms requiring medical evaluation.
Can Alli affect vitamin absorption?
Yes. The Drug Facts direct a daily multivitamin at bedtime because absorption of some vitamins can be reduced.
Can Alli cause bowel changes?
Yes. The label notes oily spotting, loose stools and more frequent bowel movements, with risk affected by dietary fat.
Is Alli suitable during pregnancy or breastfeeding?
No. The approved OTC label instructs people who are pregnant or breastfeeding not to use the product.
Do safety warnings apply to Xenical too?
Some ingredient-related risks overlap, but the Rx product has distinct clinical instructions and prescribing information.
Primary sources.
FDA labeling and consumer guidance. These sources do not endorse Alivexa or any partner merchant.